| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Is a Novel Marker Expressed by Follicular Dendritic Cells in Lymph Nodes and Tumor-Associated Lymphoid Infiltrates
From the Departments of Biomedical Science and Human Oncology,* Genetics, Biology and Biochemistry, and Clinical Physiopathology, University of Turin Medical School, Turin; the Department of Pathology and Laboratory Medicine, University of Parma, Parma; and the Center of Research and Experimental Medicine (CeRMS),¶ San Giovanni Battista Hospital, Torino, Italy
During routine assessment of the hormonal phenotype of breast carcinomas, we detected expression of the estrogen receptor (ER) in the germinal centers of reactive lymphoid follicles surrounding malignant foci. To confirm and extend this finding, we compared ER-
, progesterone receptor (PR), and androgen receptor (AR) immunostaining in hyperplastic or metastatic lymph nodes obtained from patients with various pathology, disease location, gender and age. Irrespective of these parameters, we found that: 1) ER--positive cells were located prevalently in germinal centers, 2) the PR was weakly expressed by cells within and surrounding germinal centers, and 3) the androgen receptor was undetectable. Transcripts for ER- and PR were also detected by reverse transcription-polymerase chain reaction on laser-microdissected lymph node germinal centers. Morphologically, the ER-positive cells resemble dendritic cells and by double immunostaining were found to express both CD21 and CD23, which is characteristic of follicular dendritic cells. Finally, we assessed the effects of Tamoxifen treatment by comparing the numbers of ER-positive follicular dendritic cells in lymph nodes obtained from breast cancer patients before and after treatment. The results show that Tamoxifen treatment generated larger germinal centers with more abundant ER+/CD21+/CD23+ cells. Taken together, these results open new perspectives on the effects of sex steroids and their antagonists on the human response in cancer and inflammation.
This article has been cited by other articles:
 |
|
 |
|
  M. M. Escribese, T. Kraus, E. Rhee, A. Fernandez-Sesma, C. B. Lopez, and T. M. Moran Estrogen inhibits dendritic cell maturation to RNA viruses Blood, December 1, 2008; 112(12): 4574 - 4584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Peralta, V. K. Han, J. Horrocks, B. A. Croy, and M. J. van den Heuvel CD56bright cells increase expression of {alpha}4 integrin at ovulation in fertile cycles J. Leukoc. Biol., October 1, 2008; 84(4): 1065 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Curran, B. M. Judy, N. A. Duru, H.-Q. Wang, L. A. Vergara, D. B. Lubahn, and D. M. Estes Estrogenic Regulation of Host Immunity against an Estrogen Receptor-Negative Human Breast Cancer Clin. Cancer Res., October 1, 2006; 12(19): 5641 - 5647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cernetich, L. S. Garver, A. E. Jedlicka, P. W. Klein, N. Kumar, A. L. Scott, and S. L. Klein Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Infect. Immun., June 1, 2006; 74(6): 3190 - 3203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Sander, C. G. Luchetti, M. E. Solano, E. Elia, G. Di Girolamo, C. Gonzalez, and A. B. Motta Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction, March 1, 2006; 131(3): 591 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Foulkes, K. Metcalfe, P. Sun, W. M. Hanna, H. T. Lynch, P. Ghadirian, N. Tung, O. I. Olopade, B. L. Weber, J. McLennan, et al. Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer: The Influence of Age, Grade, and Histological Type Clin. Cancer Res., March 15, 2004; 10(6): 2029 - 2034. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
